Paramjith Anand

Alcyone Therapeutics, Inc. develops novel treatment modalities for difficult neurological conditions. The company was founded by Paramjith Anand, Adam S. Fleisher, Corey M. McCann, and William L. Olbricht in 2010 and is headquartered in Lowell, MA.

Arthromeda, Inc. develops cost-effective, patient-specific solutions to improve outcomes in arthroplasty surgeries. The company was founded by Paramjith Anand and Mehran Aghazadeh in 2011 and is headquartered in Lowell, MA.

Anuncia, Inc. develops neuro therapeutic devices. The American company was founded in 2018. Elsa Chi Abruzzo has been the CEO of the company since 2018.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Toxikon Corp. provides life science and laboratory services. The firm's services include toxicology, chronic, reproductive and chronic toxicity, genetic toxicology, carcinogenicity, pharmacokinetics, toxicokinetics, and microbiology. It offers services to the pharmaceutical, medical devices, and drug companies. The company was founded in 1977 and is located in Bedford, MA.

OPKO Diagnostics LLC engages in the provision of health services. It develops blood testing devices for use in homes and doctors offices. The company was founded by Vincent Linder, George M. Whitesides, David Steinmiller, and Samuel K. Sia in 2004 and is headquartered in Woburn, MA.

Part of Katahdin Industries, Inc., Spire Optoelectronics, Inc. manufactures medical devices. The company is based in Bedford, MA. The CEOs of the company are Roger G. Little, Mark C. Little. Spire Optoelectronics was acquired by N2 Biomedical LLC, a SUB of Katahdin Industries, Inc. from Spire Corp. on September 18, 2013 for $10.50 million.

Arsenal Medical Inc. develops therapeutic products based on BioActive Composites platform. Its biomaterials-based systems provide targeted local and systemic therapies to treat chronic diseases and conditions. The firm product offers tailored dosing of drugs, mechanical and biochemical compatibility with tissues and complete bioabsorption. The company was founded by George M. Whitesides, Carmichael S. Roberts Jr. and Robert S. Langer Jr. in 2005 and is headquartered in Watertown, MA.